Cannabis Investing Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient
Daré Bioscience Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
Cannabis Investing Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group
Pharmaceutical Investing Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
Pharmaceutical Investing Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study
Pharmaceutical Investing Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma
Pharmaceutical Investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
Cannabis Investing Kalytera Announces Further Issuance of Shares under Services Agreement with Salzman Group
Pharmaceutical Investing Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
Skyharbour's Partner Company Mustang Energy Commences Field Program at 914W Uranium Project Located in the Athabasca Basin, Saskatchewan
Bold Ventures Announces Increase and Extension of Non-Brokered Private Placement and Closing of Third Tranche, and Signs Agreement with Investor News Network
